Technavio, a leading provider of market research reports, has released its latest study on Influenza Vaccine Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges. Influenza, a potentially lethal disease, necessitates annual vaccination for effective prevention. The antigenic shift and drift of influenza viruses necessitate recurring vaccination to maintain immunity against the circulating strains. Vaccination is crucial due to the varying severity and composition of seasonal influenza infections. To ensure optimal protection against the evolving virus, it is essential to receive an influenza vaccine shot annually prior to the onset of the influenza season.
The market size is estimated to grow by USD 3761.8 million, at a CAGR of 8.09% during the forecast period. Need for revaccination | Surge in number of genetic characterization studies on influenza virus | Increase in global travel
Know what is trending in the market - Access a free sample report!
The Influenza Vaccine Market is a significant segment of the global pharmaceuticals industry, encompassing entities involved in research and development (R&D) or manufacturing of both generic and non-generic drugs, as well as veterinary drugs. According to Technavio, the healthcare market size is determined by the consolidated revenue generated by providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the global pharmaceuticals sector will be fueled by several key factors, including the increasing aging population. By 2050, approximately one-quarter of the US population is projected to be over 60 years old, with Europe reaching a similar demographic milestone by 2030. This demographic shift is anticipated to drive demand for preventative healthcare solutions, including influenza vaccines.
The Influenza Vaccine Market is experiencing significant growth, fueled by the Increasing prevalence and incidence of influenza. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
For insights on company offerings- Request a sample report!
The influenza vaccine market represents a significant business opportunity due to the ongoing demand for effective preventive measures against seasonal and pandemic influenza. Market growth is driven by factors such as increasing global population, rising healthcare expenditures, and the continuous development of new vaccine technologies. Key players in this market include Sanofi Pasteur, GlaxoSmithKline, and Seqirus, who collectively account for a large market share.
The Influenza Vaccine Market has witnessed significant growth due to the availability of various types of vaccines to combat seasonal and regional epidemics caused by the influenza virus. The market includes Flu Shots, Nasal Spray Vaccines, Swine Flu Vaccines, and mRNA Vaccines, among others. The immune response to these vaccines varies, with some providing better protection against severe influenza cases than others. Trivalent and Quadrivalent vaccines are commonly used, with the latter offering protection against four strains of the virus. The Global Influenza Program works to ensure the continuous production and distribution of effective vaccines. Adult vaccines and Pediatric vaccines are available at Hospital & Retail Pharmacies. Live Attenuated Vaccines and Inactivated Vaccines are two main types, with the former containing a weakened live virus and the latter containing an inactivated virus. The vaccine strain is updated annually based on the current flu cases and deaths, making it essential to get vaccinated each year. Vaccines like mRNA vaccines have gained popularity due to their effectiveness and quick production capabilities. Combination vaccines offer protection against other diseases, making them a popular choice. Despite the availability of vaccines, regional epidemics and severe influenza cases continue to pose a threat, emphasizing the importance of continued research and vaccine development.
Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
